Updates on role of human recombinant activated protein C in patients with sepsis and severe sepsis: Changed scenario after PROWESS SHOCK trial

Benzer Materyaller

• Severe sepsis: are PROWESS and PROWESS-SHOCK trials comparable? A clinical and statistical heterogeneity analysis
  Yazar:: Kalil, Andre C, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients
  Yazar:: Martí‐Carvajal, Arturo J, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Role of human recombinant activated protein C and low dose corticosteroid therapy in sepsis
  Yazar:: Shukla, Aparna, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes
  Yazar:: Martin, Greg S
  Baskı/Yayın Bilgisi: (2012)
• Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated)
  Yazar:: Levy, Howard, ve diğerleri
  Baskı/Yayın Bilgisi: (2005)